Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Gedeon Richter Plc., today announced positive topline results for RGH-MD-53, a Phase 3 study of cariprazine for the... read more
There have been two citizen petitions (from two different companies) in the last two working days requesting that the FDA determine that Ditropan XL was not withdrawn from the market for reasons... read more
The text of H.R. 5298 is now available. When we first saw the full title of this bill it appeared that it would, if passed, result in all opioids that act at mu receptor agonists being classified... read more
Radius Health, Inc. (Nasdaq:RDUS) announced Friday (3/30/2018) that the company has initiated the Phase 3 ATOM (Abaloparatide Treatment for Osteoporosis in Males) study of abaloparatide injection... read more